[{"path":"/safety/recalls-market-withdrawals-safety-alerts/fda-cautions-pet-owners-not-feed-texas-tripe-inc-raw-pet-food-due-salmonella-listeria-monocytogenes","field_change_date_2":"08/15/2019","field_brand_name":"<a href=\"/safety/recalls-market-withdrawals-safety-alerts/fda-cautions-pet-owners-not-feed-texas-tripe-inc-raw-pet-food-due-salmonella-listeria-monocytogenes\">Texas Tripe</a>","field_product_description":"Raw frozen pet food","field_recall_reason_description":"Potential to be contaminated with Salmonella and Listeria monocytogenes","field_recall_reason":"Salmonella, Listeria","field_company_name":" Texas Tripe Inc.","field_product_type":"","term_node_tid":"Pet Food","field_regulated_product_field":"Animal &amp; Veterinary","all-terms-rewrite":"Animal &amp; Veterinary, Pet Food","publicationDate":"2019-08-15T04:00:00.000Z","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fda-cautions-pet-owners-not-feed-texas-tripe-inc-raw-pet-food-due-salmonella-listeria-monocytogenes","canonicalId":"5ae8c7f57c852cf63b1acdabf19c9e7b7573b622e45fc518d532f52266a8d0ee","title":"FDA Cautions Pet Owners Not to Feed Texas Tripe Inc. Raw Pet Food Due to Salmonella, Listeria monocytogenes","description":"FDA is cautioning pet owners not to feed pets certain lots of Texas Tripe Inc. raw pet food after samples tested positive for Salmonella, Listeria monocytogenes.","feedName":"fda","feedSource":"fda","categories":[]},{"path":"/safety/recalls-market-withdrawals-safety-alerts/pfizer-inc-issues-voluntary-nationwide-recall-2-lots-relpaxr-eletriptan-hydrobromide-40-mg-tablets","field_change_date_2":"08/15/2019","field_brand_name":"<a href=\"/safety/recalls-market-withdrawals-safety-alerts/pfizer-inc-issues-voluntary-nationwide-recall-2-lots-relpaxr-eletriptan-hydrobromide-40-mg-tablets\">RELPAX</a>","field_product_description":"RELPAX® (eletriptan hydrobromide) 40 mg tablets","field_recall_reason_description":"\tMicrobiological Contamination","field_recall_reason":"Unapproved Ingredient","field_company_name":"Pfizer Inc","field_product_type":"","term_node_tid":"","field_regulated_product_field":"Drugs","all-terms-rewrite":"Drugs, ","publicationDate":"2019-08-15T04:00:00.000Z","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pfizer-inc-issues-voluntary-nationwide-recall-2-lots-relpaxr-eletriptan-hydrobromide-40-mg-tablets","canonicalId":"cec2effad3cdd04a58e367af53881bee245d416e8a60acf4d8e33b47d8e71dba","title":"Pfizer Inc. Issues a Voluntary Nationwide Recall for 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products","description":"Pfizer Inc. is voluntarily recalling RELPAX® (eletriptan hydrobromide) 40 mg tablets, lots AR5407 and CD4565, to the Patient level. Pfizer Inc. initiated this recall because these product lots may not meet Pfizer’s in-house microbiological specification for the potential presence of Genus Pseudomona","feedName":"fda","feedSource":"fda","categories":[]}]